---
title: "Canagliflozin - Diabetes mellitus type 2"
sidebar: mydoc_sidebar
permalink: db08907-mesh-d003924-1.html
toc: false 
---


Path ID: `DB08907_MESH_D003924_1`
{% include image.html url="images/db08907-mesh-d003924-1.png" file="db08907-mesh-d003924-1.png" alt="db08907-mesh-d003924-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D000068896 | Canagliflozin | Drug |
| UniProt:P31639 | Sodium/glucose cotransporter 2 | Protein |
| GO:0035623 | Renal glucose absorption | BiologicalProcess |
| MESH:D001786 | Blood glucose | ChemicalSubstance |
| MESH:D003924 | Diabetes mellitus type 2 | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Canagliflozin | DECREASES ACTIVITY OF | Sodium/Glucose Cotransporter 2 |
| Sodium/Glucose Cotransporter 2 | PARTICIPATES IN | Renal Glucose Absorption |
| Renal Glucose Absorption | POSITIVELY REGULATES | Blood Glucose |
| Blood Glucose | POSITIVELY CORRELATED WITH | Diabetes Mellitus Type 2 |
|---------|-----------|---------|

Reference: [https://go.drugbank.com/drugs/DB08907#mechanism-of-action](https://go.drugbank.com/drugs/DB08907#mechanism-of-action){:target="_blank"}